BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 11548191)

  • 1. Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy. Presentation of a case series.
    Jongerius PH; Rotteveel JJ; van den Hoogen F; Joosten F; van Hulst K; Gabreëls FJ
    Eur J Pediatr; 2001 Aug; 160(8):509-12. PubMed ID: 11548191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy.
    Savarese R; Diamond M; Elovic E; Millis SR
    Am J Phys Med Rehabil; 2004 Apr; 83(4):304-11; quiz 312-4, 336. PubMed ID: 15024333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience.
    Mahadevan M; Gruber M; Bilish D; Edwards K; Davies-Payne D; van der Meer G
    Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():142-5. PubMed ID: 27497402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is injection of botulinum toxin type A effective in the treatment of drooling in children with cerebral palsy?
    Vaile L; Finlay F
    Arch Dis Child; 2006 Oct; 91(10):862-3. PubMed ID: 16990361
    [No Abstract]   [Full Text] [Related]  

  • 5. Botulinum toxin A as a treatment for excessive drooling in children.
    Bothwell JE; Clarke K; Dooley JM; Gordon KE; Anderson R; Wood EP; Camfield CS; Camfield PR
    Pediatr Neurol; 2002 Jul; 27(1):18-22. PubMed ID: 12160968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy.
    Gonzalez-L MD; Martinez C; Bori Y Fortuny I; Suso-Vergara S
    Am J Phys Med Rehabil; 2017 Feb; 96(2):68-76. PubMed ID: 28099276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin injections for children with excessive drooling.
    Hassin-Baer S; Scheuer E; Buchman AS; Jacobson I; Ben-Zeev B
    J Child Neurol; 2005 Feb; 20(2):120-3. PubMed ID: 15794177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary effects of botulinum toxin injections into salivary glands for the management of pediatric drooling.
    Reid SM; Walstab JE; Chong D; Westbury C; Reddihough DS
    J Craniofac Surg; 2013 Jan; 24(1):28-33. PubMed ID: 23348253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
    Banerjee KJ; Glasson C; O'Flaherty SJ
    Dev Med Child Neurol; 2006 Nov; 48(11):883-7. PubMed ID: 17044954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of salivary gland botulinum Toxin-A on drooling and respiratory morbidity in children with neurological dysfunction.
    Gubbay A; Marie Blackmore A
    Int J Pediatr Otorhinolaryngol; 2019 Sep; 124():124-128. PubMed ID: 31185343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin effect on salivary flow rate in children with cerebral palsy.
    Jongerius PH; Rotteveel JJ; van Limbeek J; Gabreëls FJ; van Hulst K; van den Hoogen FJ
    Neurology; 2004 Oct; 63(8):1371-5. PubMed ID: 15505151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B.
    Wilken B; Aslami B; Backes H
    Neuropediatrics; 2008 Aug; 39(4):200-4. PubMed ID: 19165707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-to-date report of botulinum toxin therapy in patients with drooling caused by different etiologies.
    Ellies M; Laskawi R; Rohrbach-Volland S; Arglebe C
    J Oral Maxillofac Surg; 2003 Apr; 61(4):454-7. PubMed ID: 12684962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botox(®) to reduce drooling in a paediatric population with neurological impairments: a Phase I study.
    Hay N; Penn C
    Int J Lang Commun Disord; 2011; 46(5):550-63. PubMed ID: 21899672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
    Jongerius PH; van den Hoogen FJ; van Limbeek J; Gabreëls FJ; van Hulst K; Rotteveel JJ
    Pediatrics; 2004 Sep; 114(3):620-7. PubMed ID: 15342830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drooling: are botulinum toxin injections into the major salivary glands a good treatment option?
    Nordgarden H; Østerhus I; Møystad A; Asten P; Johnsen UL; Storhaug K; Loven JØ
    J Child Neurol; 2012 Apr; 27(4):458-64. PubMed ID: 21940695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of drooling by ultrasound-guided intraglandular injections of botulinum toxin type A into the salivary glands.
    Jongerius PH; Joosten F; Hoogen FJ; Gabreels FJ; Rotteveel JJ
    Laryngoscope; 2003 Jan; 113(1):107-11. PubMed ID: 12514392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type A on oral health in treating sialorrhea in children with cerebral palsy: a randomized, double-blind, placebo-controlled study.
    Wu KP; Ke JY; Chen CY; Chen CL; Chou MY; Pei YC
    J Child Neurol; 2011 Jul; 26(7):838-43. PubMed ID: 21551374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated treatments of drooling with botulinum toxin B in neurology.
    Møller E; Daugaard D; Holm O; Winge K; Bardow A; Lykkeaa J; Belhage B; Bakke M
    Acta Neurol Scand; 2015 Jan; 131(1):51-7. PubMed ID: 25270197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric Sialorrhea: Submandibular Duct Rerouting and Intraparotid Botulinum Toxin A Injection With Literature Review.
    Calim OF; Hassouna HNH; Yildirim YS; Dogan R; Ozturan O
    Ann Otol Rhinol Laryngol; 2019 Feb; 128(2):104-112. PubMed ID: 30371109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.